Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Scott D Solomon, Jean-Claude Tardif, ELIXA Investigators

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

1059 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftThe New England Journal of Medicine
Vol/bind373
Udgave nummer23
Sider (fra-til)2247-2257
Antal sider11
ISSN0028-4793
DOI
StatusUdgivet - 2015

Fingeraftryk Dyk ned i forskningsemnerne om 'Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater

    Pfeffer, M. A., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Køber, L. V., Lawson, F. C., Ping, L., Wei, X., Lewis, E. F., Maggioni, A. P., McMurray, J. J. V., Probstfield, J. L., Riddle, M. C., Solomon, S. D., Tardif, J-C., & ELIXA Investigators (2015). Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. The New England Journal of Medicine, 373(23), 2247-2257. https://doi.org/10.1056/NEJMoa1509225